Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy (Q33313270)

25 July 2017

title

Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy (English)

1 reference

25 July 2017

0 references

0 references

1 reference

Shinya Kobayashi

1

1 reference

25 July 2017

Minoru Satoh

2

1 reference

25 July 2017

Tamehachi Namikoshi

3

1 reference

25 July 2017

Yoshisuke Haruna

4

1 reference

25 July 2017

Sohachi Fujimoto

5

1 reference

25 July 2017

Sayaka Arakawa

6

1 reference

25 July 2017

Norio Komai

7

1 reference

25 July 2017

Naruya Tomita

8

1 reference

25 July 2017

Tamaki Sasaki

9

1 reference

25 July 2017

Naoki Kashihara

10

1 reference

25 July 2017

publication date

5 January 2008

1 reference

Clinical and experimental nephrology

25 July 2017

published in

1 reference

25 July 2017

volume

12

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

119-125

1 reference

https://scigraph.springernature.com/pub.10.1007/s10157-007-0011-8

25 July 2017

exact match

0 references

cites work

Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10157-007-0011-8

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

21 January 2018

1 reference

12 December 2020

Serotonin enhances the production of type IV collagen by human mesangial cells

1 reference

12 December 2020

Serotonin-stimulated aortic endothelial cells secrete a novel T lymphocyte chemotactic and growth factor

1 reference

12 December 2020

Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects

1 reference

12 December 2020

Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus

1 reference

12 December 2020

Nitric oxide in vascular biology

1 reference

12 December 2020

Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease

1 reference

12 December 2020

Cardiovascular effects of serotonin agonists and antagonists

1 reference

12 December 2020

High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells

1 reference

12 December 2020

Diabetic nephropathy: diagnosis, prevention, and treatment

1 reference

12 December 2020

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

1 reference

12 December 2020

Functions of 5-HT2A receptor and its antagonists in the cardiovascular system

1 reference

12 December 2020

Microparticles in cardiovascular diseases.

1 reference

12 December 2020

Conjunctive effects of the 5HT(2) receptor antagonist, sarpogrelate, on thrombolysis with modified tissue plasminogen activator in different laser-induced thrombosis models

1 reference

12 December 2020

The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients

1 reference

12 December 2020

MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist

1 reference

12 December 2020

Anti-mitogenic effects of sarpogrelate in cultured rat mesangial cells

1 reference

12 December 2020

Regulatory functions of the vascular endothelium

1 reference

12 December 2020

Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy

1 reference

12 December 2020

Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease.

1 reference

12 December 2020

A novel serotonin blocker, sarpogrelate, increases circulating adiponectin levels in diabetic patients with arteriosclerosis obliterans

1 reference

12 December 2020

Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.

1 reference

12 December 2020

Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy

1 reference

12 December 2020

Serum adiponectin and renal dysfunction in men with type 2 diabetes.

1 reference

12 December 2020

10.1007/S10157-007-0011-8

Identifiers

DOI

1 reference

25 July 2017

1 reference